The insurtech firm has raised further capital from new and existing investors to support its ongoing expansion.
"We wanted to raise more in the spring but, with lockdown restrictions pending, we had to close the round early. However, since then, the business has performed incredibly well and we are seeing opportunities for new products and new markets,"
The funding from consumer specialist Piper will support expansion across the UK, US and Asia.
"Since first meeting the Piper team in 2016 they have consistently helped and supported our business. We are confident that their investment and expertise will help us realise our global ambitions for the Wattbike brand."
The funding round was led by Mercia and will support the firm in progressing its multi-cancer diagnostic programmes.
"Worldwide, 26,000 people die from cancer each day. Early detection is critical for effective treatment, but many cancers go undetected for too long. This funding is another significant step forward for ClinSpec Dx in our mission to detect cancer earlier and help to increase patient survival and quality of life."
The healthtech business raised the capital from Mercia, the Future Fund, and its founder to enhance its remote care platform.
"MyPathway has really proved its worth during the lockdown. With routine appointments having to be cancelled, it has made it so much easier for hospitals to communicate with patients and keep track of their condition."